Drawing for LYTROMBA

USPTO serial 79152570

LYTROMBA

Reviewed by CopyMark Law Group

Reg. 4753858Status 404
Filing date
Status date
Registration date
Jun 16, 2015
Examiner
LAVACHE, LINDA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LYTROMBA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Claudia A. Smith

CLAUDIA A. SMITH WHITE & CASE LLPTRADEMARK DEPT1155 AVENUE OF THE AMERICASNEW YORK, NY 10036

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, preparations for the treatment and prevention of brain and central nervous system diseases and disorders; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, depression, mood disorder, psychosis, anxiety, epilepsy, multiple sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, stroke, oncology, pain, alcoholism and dependency; medical diagnostic preparations, substances, reagents and agentsSECTION 70 - CANCELLED
010Surgical and medical apparatus and instruments, namely, examination systems consisting primarily of medical instruments for use in diagnosing central nervous system disorders; suture materials; apparatus and instruments for diagnostic purposes for diseases and disorders of the central nervous system; integrated medical systems comprised primarily of medical instruments for central nervous system related diagnostics, computer hardware and software for medical information and medical information management for web-based physical and psychological examination and assessment of patients at a distance and at a clinic; medical instruments for guidance and control of medicinesSECTION 70 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 12, 2019DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Apr 12, 2019DETHDEATH OF INTERNATIONAL REGISTRATION
Oct 24, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Oct 8, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB
Oct 8, 2015FIMPFINAL DISPOSITION PROCESSED
Sep 16, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 16, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 4, 2015GPNXNOTIFICATION PROCESSED BY IB
Mar 31, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 31, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 18, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 18, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 11, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 21, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 16, 2015ALIEASSIGNED TO LIE
Feb 13, 2015CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Feb 6, 2015CRCVCORRECTION TRANSACTION RECEIVED FROM IB
Jan 29, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 29, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 29, 2015CNEAEXAMINERS AMENDMENT MAILED
Jan 28, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 28, 2015XAECEXAMINER'S AMENDMENT ENTERED
Jan 28, 2015CNEAEXAMINERS AMENDMENT -WRITTEN
Jan 24, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jan 23, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 23, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 24, 2014RFNTREFUSAL PROCESSED BY IB
Oct 8, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 8, 2014RFRRREFUSAL PROCESSED BY MPU
Oct 8, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 7, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 7, 2014MAFRAPPLICATION FILING RECEIPT MAILED
Oct 3, 2014DOCKASSIGNED TO EXAMINER
Oct 3, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 2, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance